CLARKE MICHAEL F ET AL: "Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.", CANCER RESEARCH, vol. 66, no. 19, 1 October 2006 (2006-10-01), pages 9339-9344, XP002661633, ISSN: 1538-7445 (B1)

ZHOU JIANGBING ET AL: "Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 104, no. 41, October 2007 (2007-10), pages 16158-16163, XP002661526, ISSN: 0027-8424 -& ZHOU JIANGBING ET AL: "Corrections: Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 104, no. 49, 4 December 2007 (2007-12-04), XP002662722, (B1)

DESMOND JULIAN C ET AL: "The synthetic furanonaphthoquinone induces growth arrest, apoptosis and differentiation in a variety of leukaemias and multiple myeloma cells", BRITISH JOURNAL OF HAEMATOLOGY, vol. 131, no. 4, November 2005 (2005-11), pages 520-529, XP002661429, ISSN: 0007-1048 (B1)

FRANK DAVID A: "STAT3 as a central mediator of neoplastic cellular transformation", CANCER LETTERS, vol. 251, no. 2, June 2007 (2007-06), pages 199-210, XP022059608, ISSN: 0304-3835 (B1)

HIRAI KEI-ICHI ET AL: "Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells", CANCER DETECTION AND PREVENTION, vol. 223, no. 6, 1 January 1999 (1999-01-01), pages 539-550, XP009152976, ELSEVIER SCIENCE ISSN: 0361-090X (B1)

KATOH MASUKO ET AL: "STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review)", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, vol. 19, no. 2, 1 February 2007 (2007-02-01), pages 273-278, XP009090900, SPANDIDOS PUBLICATIONS, GR ISSN: 1107-3756 (B1)

KOYAMA ET AL.: 'Micellar electrokinetic chromatography (MEKC) separation of furanonaphthoquinones from Tabebuia impetiginosa' CHEM.PHARM.BULL. vol. 48, no. 6, June 2000, TOKYO, pages 873 - 875, XP002553570 (B1)

SOLORZANO ET AL.: 'Decreased glycotic metabolism accelerates apoptosis in response to 2-acetyl furanonaphthoquinone in K1735 melanoma irrespective of bcl-2 overexpression' CANCER BIOL.THER. vol. 4, no. 3, March 2005, pages 329 - 335, XP008132345 (B1)

US-A1- 2004 006 009 (B1)

US-A1- 2005 010 060 (B1)

US-A1- 2006 019 256 (B1)

US-A1- 2006 099 251 (B1)

US-A1- 2006 222 696 (B1)

US-A1- 2006 247 318 (B1)

US-A1- 2007 060 521 (B1)

WO-A2-2004/026253 (B1)

WO-A2-2005/033048 (B1)

WO-A2-2006/056399 (B1)

WO-A2-2006/113790 (B1)

WO-A2-2007/100640 (B1)

WO-A2-2007/115269 (B1)

YAO ET AL.: "Experimental study on the growth inhibition of bladder cancer cells by signal conduction blocker AG490", JOURNAL OF CLINICAL UROLOGY, vol. 21, no. 5, May 2006 (2006-05), pages 379-382, XP002661522, (B1)

Colman et al.: "Effect of a small molecule inhibitor of the JAK2/STAT3 pathway on self-renewal of glioblastoma stem cells", Journal of Clinical Oncology, vol. 26, no. 15S May 2008 (2008-05), XP002661523, Retrieved from the Internet: URL:http://meeting.ascopubs.org/cgi/conten t/abstract/26/15_suppl/2003?sid=22d20bba-d 0ca-4739-a434-779df098ec93 [retrieved on 2010-10-17] (B1)